Near-infrared oxidative phosphorylation inhibitor integrates acute myeloid leukemia–targeted imaging and therapy-Reference-Cited by-同舟云学术

Near-infrared oxidative phosphorylation inhibitor integrates acute myeloid leukemia–targeted imaging and therapy

Published:2021-01 Issue:1 Volume:7 Page:
ISSN:2375-2548
Container-title:Science Advances
language:en
Short-container-title:Sci. Adv.

Author:

Zhang Chi¹^ORCID,Liu Tao¹,Luo Peng¹,Gao Li²,Liao Xingyun¹,Ma Le¹,Jiang Zhongyong¹,Liu Dengqun¹,Yang Zeyu¹,Jiang Qingzhi¹,Wang Yu¹,Tan Xu¹,Luo Shenglin¹^ORCID,Wang Yang¹^ORCID,Shi Chunmeng¹^ORCID

Affiliation:

1. Institute of Rocket Force Medicine, State Key Laboratory of Trauma, Burns and Combined Injury, College of Preventive Medicine, Third Military Medical University (Army Medical University), Chongqing 400038, China.

2. Department of Hematology, Xinqiao Hospital, Third Military Medical University (Army Medical University), Chongqing 400037, China.

Abstract

A near-infrared mitochondrial dye serves as novel oxidative phosphorylation inhibitor for acute myeloid leukemia–targeted imaging.

Funder

Natural Science Foundation Programs

Innovation team building program of Chongqing University

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference41 articles.

1. Acute Myeloid Leukemia